CNPAX
Price
$73.42
Change
+$0.12 (+0.16%)
Updated
Dec 4 closing price
Net Assets
162.64B
PRJBX
Price
$48.10
Change
+$0.19 (+0.40%)
Updated
Dec 3 closing price
Net Assets
6B
Interact to see
Advertisement

CNPAX vs PRJBX

Header iconCNPAX vs PRJBX Comparison
Open Charts CNPAX vs PRJBXBanner chart's image
American Funds New Perspective 529A
Price$73.42
Change+$0.12 (+0.16%)
VolumeN/A
Net Assets162.64B
PGIM Jennison Global Opportunities R2
Price$48.10
Change+$0.19 (+0.40%)
VolumeN/A
Net Assets6B
CNPAX vs PRJBX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. PRJBX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and PRJBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. PRJBX (6B). CNPAX pays higher dividends than PRJBX: CNPAX (0.46) vs PRJBX (0.00). CNPAX was incepted earlier than PRJBX: CNPAX (24 years) vs PRJBX (7 years). PRJBX (1.36) is less costly to investors than CNPAX (0.77). PRJBX is a more actively managed with annual turnover of: 66.00 vs. CNPAX (24.00). PRJBX has a lower initial minimum investment than CNPAX: PRJBX (0) vs CNPAX (250). CNPAX annual gain was more profitable for investors over the last year : 11.91 vs. PRJBX (-1.43). CNPAX return over 5 years is better than : 25.34 vs. PRJBX (7.10).
CNPAXPRJBXCNPAX / PRJBX
Total Expense Ratio0.771.3457%
Annual Report Gross Expense Ratio0.771.3657%
Fund Existence24 years7 years-
Gain YTD20.1057.823257%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets163B6B2,717%
Annual Yield % from dividends0.460.00-
Returns for 1 year11.91-1.43-831%
Returns for 3 years46.1062.5574%
Returns for 5 years25.347.10357%
Returns for 10 years101.99N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM11.120.63
+6.01%
Contineum Therapeutics
LOB33.281.11
+3.45%
Live Oak Bancshares
ALSN90.521.20
+1.34%
Allison Transmission Holdings
ATMVU7.75N/A
N/A
AlphaVest Acquisition Corp
CTSO0.73-0.04
-4.67%
Cytosorbents Corp